Real-world efficacy and safety of dupilumab use in the treatment of asthma

Ann Allergy Asthma Immunol. 2021 Jul;127(1):147-149. doi: 10.1016/j.anai.2021.04.011. Epub 2021 Apr 10.

Authors

Somaira Nowsheen¹, Jared I Darveaux²

Affiliations

¹ Gundersen Lutheran Medical Foundation, La Crosse, Wisconsin.
² Department of Allergy and Immunology, Gundersen Health System, Onalaska, Wisconsin. Electronic address: jidarvea@gundersenhealth.org.

PMID: 33848633
DOI: 10.1016/j.anai.2021.04.011

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Antibodies, Monoclonal, Humanized / administration & dosage*
Antibodies, Monoclonal, Humanized / adverse effects
Asthma / drug therapy*
Child
Female
Humans
Male
Middle Aged
Respiratory Function Tests
Treatment Outcome
Young Adult

Substances

Antibodies, Monoclonal, Humanized
dupilumab